AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)
Closed Posted
- Opportunity number
- HRSA-25-046
- Agency
-
Health Resources and Services Administration
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
-
- 93.917 HIV Care Formula Grants
- Funding instrument
- Grant
- Category
-
- Health
- Eligible applicants
-
- Other
- State Governments
Opportunity details come from Grants.gov. Updated .
About this opportunity
The Health Resources and Services Administration (HRSA) is offering the AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) grant to provide funding to states and territories that demonstrate a need for additional resources to prevent, reduce, or eliminate ADAP waiting lists. Eligible applicants are limited to states and territories that receive Ryan White HIV/AIDS Program Part B funding and meet specific criteria. The grant opportunity will be evaluated based on the applicant's ability to successfully demonstrate the need for additional funding, with priority given to addressing existing waiting lists. The application deadline is November 4, 2024, and awards are expected to be made on or around April 1, 2025.
Up to $75 million in total funding is available, with individual awards ranging from $100,000 to $10 million for applicants with an existing waiting list, or up to $7 million for those without a waiting list. The funding will be provided under the HIV Care Formula Grants program (CFDA 93.917) and is authorized under Sections 311(c) and 2616 of the Public Health Service Act.
Synopsis
This notice announces the opportunity to apply for funding under the Ryan White HIV/AIDS Program (RWHAP) Part B AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF). The Health Resources and Services Administration (HRSA), HIV/AIDS Bureau (HAB), Division of State HIV/AIDS Programs (DSHAP) administers this program. ADAP ERF awards are intended for states/territories that demonstrate the need for additional resources to address a reduction in available resources to fund ADAP. HRSA will base ADAP ERF awards upon your ability to successfully demonstrate need for additional funding. An external merit review panel (MRP) will evaluate this need based on criteria published in this notice of funding opportunity (NOFO), with priority given to addressing existing waiting lists. HRSA first funded the ADAP ERF initiative in August 2010, when numerous states/territories were experiencing ADAP waiting lists. At the time of this NOFO publication, there are no ADAP waiting lists. States/territories that establish a waiting list after the publication of this NOFO must report the waiting list to HRSA immediately and use funding awarded under this NOFO to remove clients from the waiting list. Previously, eligibility for this funding was limited to states/territories that had historically imposed waiting lists. HRSA continues to anticipate potential increases in clients in need of ADAP services due to reductions in program income or rebates, loss of health care coverage among people with HIV, and increased case finding. States/territories may use ERF funds to address current or projected increases in treatment needs aligned with ending the HIV epidemic in the U.S. or other increases in the number of clients in their ADAP.
Files
| File | Type | Posted |
|---|---|---|
| hrsa 25-046 Final.pdf | ||
| hrsa-25-046 Modification.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity